DUBLIN, Aug. 15, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it is lifting a temporary stay of its litigation against the U.S. Food and Drug Administration (FDA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results